natgillin/translations-raw huggingface dataset:
- Patients have a 24% increased risk of mortality with any antibiotic-resistant Pseudomonas aeruginosa infection [13].
- Pri bolnikih, okuženih z bakterijo Pseudomonas aeruginosa, odporno proti antibiotikom, je umrljivost večja za 24 % [13].
European Antibiotic Awareness Day scarf
EVROPSKA POBUDA NA PODROCJU ZDRAVJA
Terms of use
Pogoji uporabe
ECDC would like to hear from you!
ECDC želi slišati vaše predloge!
Instructions for use of these materials
Navodila za uporabo tega gradiva
ECDC would be interested to know how and where the campaign communication materials are used, particularly if you think that your initiatives could be listed on the ‘National activities' page of this website.
Center ECDC zanima, kako se komunikacijsko gradivo kampanje uporablja in kje, zlasti če menite, da bi vaše pobude lahko bile navedene na strani „Nacionalne dejavnosti" spletnega mesta.
Permission to use the European Antibiotic Awareness Day campaign communication materials is granted to all non-profit organizations and healthcare associations as well as all European healthcare authorities and governmental bodies conducting campaigns aimed at reducing antibiotic resistance and promoting the appropriate use of antibiotics.
Dovoljenje za uporabo komunikacijskega gradiva kampanje Evropski dan ozaveščanja o antibiotikih imajo vse nepridobitne organizacije in zdravstvena združenja ter vsi evropski zdravstveni in vladni organi, ki izvajajo kampanje, namenjene zmanjševanju odpornosti proti antibiotikom, in spodbujajo ustrezno uporabo antibiotikov.
For any questions you may have on the materials, please contact: EAAD@ecdc.europa.eu
Če imate kakršna koli vprašanja glede gradiva, nam pišite na: EAAD@ecdc.europa.eu
For further detailed information and ideas how to use these materials and organise a campaign on self-medication with antibiotics, please see the Guidance note.
Podrobnejše informacije in zamisli o tem, kako uporabljati to gradivo in organizirati kampanjo o samozdravljenju z antibiotiki, najdete v navodilih.
Any other entities must obtain the consent of the ECDC before using the European Antibiotic Awareness Day campaign communication materials.
Vsi drugi subjekti morajo pred uporabo komunikacijskega gradiva kampanje Evropski dan ozaveščanja o antibiotikih pridobiti soglasje Evropskega centra za preprečevanje in obvladovanje bolezni (ECDC).Za pridobitev dovoljenja za uporabo tega gradiva pišite na: EAAD@ecdc.europa.eu
See the survey results
Sporočilo, namenjeno zdravstvenim delavcem
Provide guidelines for specimen collection, storage and transport [98,99].
Pripravite smernice za zbiranje, shranjevanje in prenašanje vzorcev [98,99].
Your tasks related to improving antibiotic use include [31,98-100] [expert consensus]:
Vaše naloge v zvezi z izboljšanjem uporabe antibiotikov vključujejo [31,98-100] [strokovno usklajeno]:
g) Providing guidelines for appropriate specimen collection, enforcing rejection criteria for specimens submitted inappropriately, and establishing procedures to limit the work-up of contaminants (e.g. blood cultures);
g) zagotavljanje smernic za primerno zbiranje vzorcev, uveljavljanje meril za zavrnitev vzorcev, ki niso bili primerno odvzeti, in vzpostavljanje postopkov, ki preprečujejo kontaminacijo (npr.
Ensure that laboratory testing and antimicrobial susceptibility reporting follow treatment guidelines (including selective reporting), and include relevant comments on interpretation if needed [31].
Zagotovite, da se pri laboratorijskem testiranju in poročanju o protimikrobni občutljivosti upoštevajo terapevtske smernice (vključno s selektivnim poročanjem) ter da po potrebi vključujejo ustrezne pripombe k razlagi [31].
b) Collaborating with the infectious disease specialist and the hospital pharmacist to implement the antibiotic stewardship programme;
b) sodelovanje z infektologom in bolnišničnim farmacevtom pri izvajanju programa za nadzor nad rabo antibiotikov;
Train hospital prescribers regularly on antibiotic resistance, and on use of rapid and point-of-care diagnostic tests [31,53].
Redno izobražujte vse zdravnike, ki predpisujejo zdravila, o odpornosti proti antibiotikom ter o uporabi hitrega diagnostičnega testiranja na mestu oskrbe [31,53].
e) Communicating critical results promptly to the treating physician;
e) takojšnje poročanje o kritičnih izvidih lečečemu zdravniku;
Provide data on antibiotic resistance at hospital level and ward level, and communicate trends to the antibiotic stewardship team and the infection prevention and control team [101].
Podatke o odpornosti proti antibiotikom v bolnišnici in po oddelkih poročajte skupini za nadzor nad rabo antibiotikov ter skupini za preprečevanje in obvladovanje okužb [101].
c) Supporting evidence-based hospital antibiotic guidelines for common infections and for surgical prophylaxis;
c) podpiranje z dokazi podprtih bolnišničnih smernic o antibiotikih pri pogostih okužbah in kirurški profilaksi;
i) Identifying critical trends in antibiotic resistance in the hospital and promptly communicating observations to the antibiotic stewardship team and the infection control team.
i) prepoznavanje pomembnih pojavov glede odpornosti proti antibiotikom v bolnišnici in takojšnje posredovanje opažanj skupini za nadzor nad rabo antibiotikov ter skupini za obvladovanje okužb;
Ensure that testing and reporting of microbiology results follow European and national standards (i.e. European Committee on Antimicrobial Susceptibility Testing - EUCAST) [31].
Evropskega odbora za testiranje protimikrobne občutljivosti - EUCAST) in nacionalni standardi (Slovenske komisije za ugotavljanje občutljivosti za protimikrobna zdravila - SKUOPZ) [31].
h) Guiding empirical antibiotic therapy by providing hospital and ward specific (e.g. intensive care unit or emergency department) cumulative antimicrobial susceptibility data;
h) vodenje empiričnega antibiotičnega zdravljenja z zagotavljanjem zbirnih podatkov testiranja protimikrobne občutljivosti za bolnišnico ali posamezne oddelke (npr.
d) Timely identification and reporting of microorganisms (e.g. in blood cultures) and antimicrobial susceptibility testing;
d) pravočasno prepoznavanje in poročanje o mikroorganizmih (npr.
Ensure that identification and antimicrobial susceptibility testing results are communicated to prescribers, nurses and the antibiotic stewardship team especially for critical results (e.g. blood cultures) [98-100].
Zagotovite, da se rezultati testiranj v zvezi s prepoznavanjem in protimikrobno občutljivostjo posredujejo zdravnikom, ki predpisujejo zdravila, negovalnemu osebju in skupini za nadzor na rabo antibiotikov, zlasti v primeru kritičnih izvidov (npr.
j) Managing your hospital's antimicrobial formulary (i.e., list of drugs available for prescribers).
j) vodenje bolnišničnih katalogov protimikrobnih zdravil (npr.
f) Presenting data in a way that supports prudent antibiotic use, for example by selectively reporting to physicians a limited number of antimicrobial susceptibility results;
f) predstavljanje podatkov na način, ki podpira preudarno rabo antibiotikov, npr.
The proposed activities are presented in three sections that are targeting the general public, primary care prescribers and hospital prescribers.
Glavna ciljna javnost so predpisovalci antibiotikov v bolnišnicah.
communication toolkit
slika komplet informativnega gradiva
The research showed that there is already some social media activity on prudent antibiotic use and that a few potential influencers are emerging.
Fotografija za ponazoritev preudarne uporabe antibiotikov v bolnišnicah, ki jo je mogoče prenesti
This guidance document is based on research of social media activity related to antibiotic use at EU level, as well as on a survey of the social media activities of EAAD partner organisations, mostly EU umbrella organisations of patients and health professionals (see Appendix 2 for full list).
Sekundarna javnost so direktorji bolnišnic in deloma tudi farmacevti v bolnišnicah ter farmacevtski odbori/odbori za usmerjanje uporabe antibiotikov.
d) Educating staff on infectious diseases and prudent use of antibiotics.
d) izobraževanje osebja o nalezljivih boleznih in preudarni rabi antibiotikov.
Clinical tasks related to improving antibiotic use include [102] [expert consensus]:
Klinične naloge v zvezi z izboljšanjem rabe antibiotikov so [102] [strokovno usklajeno]:
e) Informing patients (and their families) about the indication for an antibiotic prescription, possible side effects, and their proper use.
e) obveščanje bolnikov (in njihovih družinskih članov) o indikaciji za zdravljenje z antibiotiki, možnih neželenih učinkih in njihovi pravilni rabi.
This should include the indication, drug choice, dose, route of administration and duration of treatment.
To bi moralo vključevati indikacijo, izbiro zdravil, odmerek, način dajanja zdravila in trajanje zdravljenja;
c) Strengthening real-time follow-up and interpretation of microbiological culture data, by coordinating with the microbiology laboratory to efficiently share results to prescribers.
c) izboljšanje nadaljnjega spremljanja v realnem času in interpretacije rezultatov mikrobioloških kultur v sodelovanju z mikrobiološkim laboratorijem za učinkovito posredovanje rezultatov vsem zdravnikom, ki predpisujejo zdravila;
b) Ensuring guidelines incorporate local microbiology and antibiotic resistance patterns, and reflect existing hospital formulary.
b) zagotavljanje, da smernice vključujejo lokalne mikrobiološke in antibiotične vzorce odpornosti ter da odražajo obstoječi bolnišnični katalog zdravil;
For patients with a severe infection, initiate effective antibiotic treatment as soon as possible [31,74].
Pri bolnikih s hudo okužbo čim prej začnite učinkovito zdravljenje z antibiotiki [31,74].
b) Deciding on the first antibiotic dose for inpatients;
b) odločanje o prvem odmerku antibiotika za hospitalizirane bolnike;
c) Taking relevant cultures, before starting antibiotic therapy, which will allow antibiotic therapy to be tailored or stopped during hospitalisation;
c) odvzem ustreznih kužnin pred začetkom zdravljenja z antibiotiki, kar omogoča, da se zdravljenje z antibiotiki med hospitalizacijo prilagodi ali preneha;
Antibiotic regimens started in your department strongly influence what therapy is continued in the hospital and community settings [77].
Režim jemanja antibiotikov, ki se začne na vašem oddelku, močno vpliva na nadaljevanje zdravljenja v bolnišnici in skupnosti [77].
You are in an important position to improve antibiotic prescribing in both inpatients and outpatients, since your facility sits at the interface of the hospital and the community [77].
Ste na pomembnem položaju, ki vam omogoča da izboljšate predpisovanje antibiotikov za bolnike v bolnišnici in zunaj nje, saj vaša ustanova povezuje bolnišnico in skupnost [77].
Remain aware of local antibiotic resistance patterns in the community, hospital and department [31] [expert consensus].
Seznanite se z odpornostjo proti antibiotikom v svoji skupnosti, bolnišnici in na oddelku [31] [strokovno usklajeno].
Follow antibiotic treatment protocols, based on evidence-based guidelines (e.g. for sepsis [74], urinary tract infections [103], skin and soft tissue infections [104]), and apply infection prevention and control measures that are established in your setting [31] [expert consensus].
za sepso [74], okužbe sečil [103], okužbe kože in mehkih tkiv [104]) ter izvajajte ukrepe preprečevanja in obvladovanja okužb, ki so uveljavljene v vašem okolju [31] [strokovno usklajeno].
d) Communicating all relevant patient background and treatment decisions to in- or out-patient follow-up practitioners.
d) sporočanje vseh ustreznih informacij o anamnezi bolnika in odločitvah v zvezi z zdravljenjem zdravnikom v bolnišnici in zunaj nje, ki bodo prevzeli primer;
a) Following local evidence-based antibiotic guidelines for common infections;
a) upoštevanje lokalnih, z dokazi podprtih smernic o rabi antibiotikov pri pogostih okužbah;
a) Making available evidence-based hospital antibiotic guidelines and clinical pathways for diagnosing, treating and managing the most common infections encountered in your department (i.e. respiratory tract infections, skin and soft tissue infections, urinary tract infections and sepsis).
a) dajanje na voljo razpoložljivih, z dokazi podprtih smernic o rabi antibiotikov ter kliničnih poti za diagnosticiranje, zdravljenje in obvladovanje najpogostejših okužb, s katerimi se srečujete na vašem oddelku (npr.
Remove this filter Type: toolkit material
komplet informativnega gradiva, videoposnetek
healthcare workers in hospitals
EVROPSKA POBUDA NA PODROCJU ZDRAVJA
Antibiotic stewardship programmes, together with infection prevention and control practices, can increase patient safety and quality of care and reduce hospital costs across all services by improving how antibiotics are used, as well as by decreasing C. difficile infections and other adverse events
Bakterije, odporne proti antibiotikom, pomenijo nevarnost za vse nas, ker povzročajo okužbe, ki jih je težko zdraviti.
Key messages for junior doctors and students
Povzetek dejstev za strokovnjake
Up to a half of all antibiotic use in European hospitals is unnecessary or inappropriate.
Šestina Evropejcev se ne zaveda, da napačna uporaba antibiotikov zmanjša njihovo učinkovitost (podnapisi)
What is ECDC doing to keep antibiotics working?
Kaj počne center ECDC za ohranjanje učinkovitosti antibiotikov?
Each year across Europe, EAAD is marked on 18 November.
Evropski dan ozaveščanja o antibiotikih po vsej Evropi vsako leto obeležujemo 18. novembra.
ECDC also partners with numerous professional and patient organisations, the European Commission, the European Food Safety Authority, the European Medicines Agency and the World Health Organization Regional Office for Europe, as well international campaigns in the United States, Australia, New Zealand, Canada and Japan, to undertake a number of actions to address antimicrobial resistance.
Center ECDC se tudi partnersko povezuje s številnimi strokovnimi organizacijami in organizacijami bolnikov, Evropsko komisijo, Evropsko agencijo za varnost hrane, Evropsko agencijo za zdravila in regionalnim uradom Svetovne zdravstvene organizacije za Evropo ter mednarodnimi kampanjami v Združenih državah Amerike, Avstraliji, na Novi Zelandiji, v Kanadi in na Japonskem ter s številnimi ukrepi obravnava odpornost proti antimikrobikom.
Activities related to this topic at ECDC take place under the Antimicrobial Resistance and Healthcare-associated Infections programme .
Dejavnosti, povezane s to temo v centru ECDC, potekajo v okviru programa za preprečevanje odpornosti proti antimikrobikom in okužb, povezanih z zdravstveno oskrbo .
ECDC's main areas of work include surveillance, epidemic intelligence, developing evidence-based guidance and systematic reviews, training, support to the EU Member States.
Med glavnimi področji dela centra ECDC so nadzor, epidemiološko obveščanje, oblikovanje smernic, podprtih z dokazi, in sistematičnih pregledov, usposabljanje, podpora državam članicam EU.
Since 2008, ECDC coordinates the European Antibiotic Awareness Day, a public health initiative which aims to provide a platform and support for national campaigns on the prudent use of antibiotics.
Center ECDC od leta 2008 usklajuje evropski dan ozaveščanja o antibiotikih, evropsko pobudo za javno zdravje, katere namen je zagotoviti ustrezno platformo in podpirati nacionalne kampanje za preudarno rabo antibiotikov.
ECDC also launched, and regularly updates, a directory of online resources for the prevention and control of antimicrobial resistance and healthcare-associated infections to support EU Member States that need to develop national guidelines.
Center ECDC je tudi vzpostavil in redno posodablja imenik spletnih virov za preprečevanje in obvladovanje odpornosti proti antimikrobikom in okužb, povezanih z zdravstveno oskrbo, s čimer podpira države članice EU, ki morajo oblikovati nacionalne smernice .
The European Centre for Disease Prevention and Control (ECDC) contributes to keep antibiotics working by ensuring that Europe has a good overview of the situation on antibiotic resistance and antibiotic consumption with a yearly update of its European surveillance data, and actively promotes and advocates prudent use of antibiotics.
Evropski center za preprečevanje in obvladovanje bolezni (ECDC) k ohranjanju učinkovitosti antibiotikov prispeva tako, da z letnim posodabljanjem evropskih nadzornih podatkov skrbi, da imamo v Evropi dober pregled nad stanjem odpornosti proti antibiotikom in njihovo porabo, ter aktivno spodbuja in zagovarja preudarno rabo antibiotikov.
Twitter Facebook Linked In Mail
grafični prikaz informacij informativno gradivo komplet informativnega gradiva
information material toolkit material
slika komplet informativnega gradiva
Checklist for prescribers in hospitals and other healthcare settings
Komplet informativnega gradiva za predpisovanje antibiotikov v bolnišnicah
The toolkit contains template materials and some suggested key messages focusing on self-medication with antibiotics, ideas for awareness raising activities, and suggested tactics for getting the messages across to the general public regarding prudent use of antibiotics, especially to people self-medicating with antibiotics.
Komplet informativnega gradiva vsebuje predloge dokumentov in nekaj predlaganih ključnih sporočil, ki se osredotočajo na samozdravljenje z antibiotiki, zamisli za dejavnosti ozaveščanja in predlagane pristope za seznanjanje širše javnosti s preudarno uporabo antibiotikov, zlasti tistih oseb, ki antibiotike uporabljajo na lastno pest.
Management of these risks as well as of the factors that contribute to control of communicable diseases are under the responsibility of each EU Member State.
Obvladovanje teh tveganj in tudi dejavnikov, ki prispevajo k obvladovanja nalezljivih bolezni, je v pristojnosti posamezne države članice EU.
Activities related to this topic at ECDC, take place under the Antimicrobial Resistance and Healthcare-associated Infections programme .
Dejavnosti, povezane s to temo v centru ECDC, potekajo v okviru programa za preprečevanje odpornosti proti mikrobom in okužb, povezanih z zdravstveno oskrbo .
Since 2008, numerous health-related and professional organisations, as well as the European Commission and the World Health Organization Regional Office for Europe (WHO/Europe), have partnered with ECDC in preparing communications materials and planning activities targeting audiences such as the general public and professionals in hospitals.
Od leta 2008 so številne zdravstvene in strokovne organizacije ter Evropska komisija in Regionalni urad Svetovne zdravstvene organizacije (SZO) za Evropo kot partnerji sodelovali s centrom ECDC pri pripravi komunikacijskih gradiv in načrtovanju dejavnosti, namenjenih ciljnim skupinam, kot so splošna javnost in strokovni delavci v bolnišnicah.
ECDC's main areas of work include surveillance, epidemic intelligence, developing evidence-based guidance and systematic reviews, training, support to the EU Member States.
Med glavnimi področji dela centra ECDC so nadzor, epidemiološko obveščanje, razvijanje smernic, podprtih z dokazi, in sistematičnih pregledov, usposabljanje, podpora državam članicam EU.
Finally, on 18 November each year, ECDC coordinates the European Antibiotic Awareness Day.
Nazadnje, center ECDC vsako leto 18. novembra usklajuje evropski dan ozaveščanja o antibiotikih.
The mandate of ECDC is to identify and assess the risks of communicable diseases for EU citizens and communicate about these risks; this includes the area of antimicrobial resistance.
Center ECDC je pristojen za opredelitev in oceno tveganj nalezljivih bolezni za državljane EU ter obveščanje o teh tveganjih, kar vključuje tudi področje odpornosti proti mikrobom.
ECDC also launched, and regularly updates, a directory of online resources for the prevention and control of antimicrobial resistance and healthcare-associated infections to support EU Member States that need to develop national guidelines.
Center ECDC je tudi vzpostavil in redno posodablja imenik spletnih virov za preprečevanje in obvladovanje odpornosti proti mikrobom in okužb, povezanih z zdravstveno oskrbo, s čimer podpira države članice EU, ki morajo oblikovati nacionalne smernice.
In addition, more than 43 countries in the European region have had campaigns since that year, all under the EAAD umbrella.
Poleg tega je od navedenega leta več kot 43 držav v evropski regiji pripravilo kampanje pod okriljem evropskega dneva ozaveščanja o antibiotikih.
The European Centre for Disease Prevention and Control (ECDC) decided in 2008 to establish the European Antibiotic Awareness Day (EAAD) on 18 November as a platform for providing support to national campaigns across the region.
Evropski center za preprečevanje in obvladovanje bolezni (ECDC) je leta 2008 odločil, da bo 18. november evropski dan ozaveščanja o antibiotikih, in tako zagotovil platformo za zagotavljanje podpore nacionalnim kampanjam v regiji.
Following adoption of the European Union (EU) Council Recommendation on the prudent use of antimicrobial agents in human medicine in November 2001, which stated that EU Member States should inform the general public of the importance of prudent use of antimicrobial agents and the success of some national campaigns, such as Belgium and France, the European Centre for Disease Prevention and Control (ECDC) decided in 2008 to establish the European Antibiotic Awareness Day (EAAD) on 18 November as a platform for providing support to national campaigns across the region.
EU je novembra 2001 sprejela Priporočilo Sveta o preudarni rabi protimikrobnih sredstev v humani medicini, v katerem je bilo navedeno, da morajo države članice EU obvestiti splošno javnost o pomenu preudarne uporabe protimikrobnih sredstev, predstavljen pa je bil tudi uspeh nekaterih nacionalnih kampanj, npr.
Since 2015, the World Health Organization leads the World Antibiotic Awareness Week , a global campaign taking place on the week of the 18 November.
Svetovna zdravstvena organizacija od leta 2015 vodi svetovni teden ozaveščanja o antibiotikih , tj.
EAAD partners with World Antibiotic Awareness Week
Evropski dan ozaveščanja o antibiotikih kot partner sodeluje pri svetovnem tednu ozaveščanja o antibiotikih.
Consider these messages in addition to those for the specific target groups that relate to your area of specialisation.
Ta sporočila upoštevajte poleg tistih za posebne ciljne skupine za vaše področje specializacije.
c) Have you checked for recent antibiotic use, drug allergies, use of immunosuppressive therapy, recent hospitalisation or institutionalisation, recent travel outside of Europe, and microbiology results for the previous 3 months?
c) Ali ste preverili nedavno rabo antibiotikov, alergije na zdravila, uporabo imunosupresivnih zdravil, nedavno hospitalizacijo ali institucionalizacijo, nedavno potovanje zunaj Evrope in mikrobiološke rezultate v preteklih treh mesecih?
a) Is there a high probability of a bacterial infection, rather than colonisation or a viral infection?
a) Ali obstaja večja verjetnost za bakterijsko okužbo kot za kolonizacijo ali virusno okužbo?
• Seek guidance and advice from a senior colleague or a member of the antibiotic stewardship team;
• za smernice in nasvet prosite starejšega sodelavca ali člana skupine za nadzor nad rabo antibiotikov;
d) Does the patient have an infection that will respond to antibiotics?
d) Ali ima bolnik okužbo, ki se bo odzvala na antibiotike?
If in doubt, consult with antibiotic stewardship team [31,42,53,70,71]:
Če imate pomisleke, se posvetujte s skupino za nadzor nad rabo antibiotikov [31,42,53,70,71]:
Learn and apply all antibiotic use and infection prevention and control recommendations that are relevant to your area of specialisation [expert consensus].
Izobražujte se in upoštevajte vsa priporočila v zvezi z nadzorom nad rabo antibiotikov ter preprečevanjem okužb, ki so pomembna za vaše področje specializacije [strokovno usklajeno].